Abstract dark background with wavy patterns made of evenly spaced small purple dots.

2023

AWARD WINNING DESIGN

Larkspur Biosciences Rebrand

Scroll

Larkspur Biosciences

Elevating a Series B milestone with a strong brand and investor story: Financing milestones are critical moments for biotechs to sharpen positioning and build momentum with investors and partners.

01

Research

02

Strategy

03

Design

04

Development

challenge

Ahead of its Series B financing, Larkspur required a clear narrative and refreshed brand presence across key channels to reinforce differentiation, strengthen positioning, and set the stage for its next phase of growth.

solution

SCIENT delivered a communications refresh that included a website reskin, refined messaging framework, updated brand identity, and a redesigned investor deck with modernized graphics and content. These efforts enabled Larkspur to announce its Series B with confidence and present a cohesive story to stakeholders across the biotech ecosystem.

Brand refresh

Two business cards on concrete; one shows the Larkspur logo, the other has Larkspur logo, Catherine Sabatos-Peyton, Ph.D., Chief Executive Officer, and a purple-pink abstract cluster design.
Two business cards on concrete; one shows the Larkspur logo, the other has Larkspur logo, Catherine Sabatos-Peyton, Ph.D., Chief Executive Officer, and a purple-pink abstract cluster design.
Two business cards on concrete; one shows the Larkspur logo, the other has Larkspur logo, Catherine Sabatos-Peyton, Ph.D., Chief Executive Officer, and a purple-pink abstract cluster design.
Two business cards on concrete; one shows the Larkspur logo, the other has Larkspur logo, Catherine Sabatos-Peyton, Ph.D., Chief Executive Officer, and a purple-pink abstract cluster design.
Two business cards on concrete; one shows the Larkspur logo, the other has Larkspur logo, Catherine Sabatos-Peyton, Ph.D., Chief Executive Officer, and a purple-pink abstract cluster design.
Two business cards on concrete; one shows the Larkspur logo, the other has Larkspur logo, Catherine Sabatos-Peyton, Ph.D., Chief Executive Officer, and a purple-pink abstract cluster design.
Two business cards on concrete; one shows the Larkspur logo, the other has Larkspur logo, Catherine Sabatos-Peyton, Ph.D., Chief Executive Officer, and a purple-pink abstract cluster design.
Two business cards on concrete; one shows the Larkspur logo, the other has Larkspur logo, Catherine Sabatos-Peyton, Ph.D., Chief Executive Officer, and a purple-pink abstract cluster design.
Two business cards on concrete; one shows the Larkspur logo, the other has Larkspur logo, Catherine Sabatos-Peyton, Ph.D., Chief Executive Officer, and a purple-pink abstract cluster design.
Two business cards on concrete; one shows the Larkspur logo, the other has Larkspur logo, Catherine Sabatos-Peyton, Ph.D., Chief Executive Officer, and a purple-pink abstract cluster design.
Two business cards on concrete; one shows the Larkspur logo, the other has Larkspur logo, Catherine Sabatos-Peyton, Ph.D., Chief Executive Officer, and a purple-pink abstract cluster design.
Two business cards on concrete; one shows the Larkspur logo, the other has Larkspur logo, Catherine Sabatos-Peyton, Ph.D., Chief Executive Officer, and a purple-pink abstract cluster design.
Website homepage for Larkspur Biosciences highlighting cancer immune evasion research with an illustration of immune cells attacking a cancer cell.

Color palette

Purple

RGB
CMYK
#56036B

Lilac

RGB
CMYK
#9A80E9

Yellow

RGB
CMYK
#E6A302

Gray

RGB
CMYK
#DFDFDF

Maroon

RGB
CMYK
#801F4D

Orange

RGB
CMYK
#ED4D39

Blue

RGB
CMYK
#241B49

Sky

RGB
CMYK
#50CACA

Scientific graphic

Diagram showing tumor cell on the left with labeled target oncogene and immune regulating target, linked by dashed arrow to immune cell on the right with labeled controls immune cell box and target receptor diamond, highlighting waves 1, 2, 3, and new wave.

website

Comparison of two website homepage designs for Larkspur Biosciences, with a 'before' showing a sunset landscape and text about precision immunotherapies, and an 'after' with a white background, cancer cell illustration, and text about stopping immune evasion.Two smiling scientists in white lab coats looking at a tablet, promoting collaboration and innovation at Larkspur Biosciences.Comparison of two pipeline program charts labeled 'Before' and 'After' showing progress bars for Program 1, 2, and 3 across phases: Target Validation, Lead Discovery, Lead Optimization, and IND-Enabling.